P&G’s super-premium SK-II skin-care brand is growing at a 20% clip and accumulating new users just as quickly, thanks in large part to its “Change Destiny” campaign, CFO Jon Moeller said at the Deutsche Bank Global Consumer Conference June 14. The firm is also reaping the benefits of Gillette razor investments and price cuts, but threats remain.
Procter & Gamble Co.’s SK-II skin care line in Asia has been growing around 20% for 14 consecutive quarters, building equity and attracting new customers through sharp digital campaigns and retail execution, CFO Jon Moeller said at the Deutsche Bank Global Consumer Conference June 14.
“In markets in which we compete, SK-II is running neck and neck for the No. 1 position of super-premium skin...
Following Energy and Commerce Health Subcommittee hearing about FDA’s human food and tobacco programs on 10 September, gap between what the trade groups, committee leadership and the FDA each want more of doesn’t appear to be shrinking.
The gut’s microbiome will shape future medical advances, offering personalized therapies and prevention strategies for a wide range of diseases.
At one year, TikTok Shop conjures the early days of Amazon, representing the ‘Wild West’ of beauty ecommerce, said co-founders of private label and contract manufacturing company KO-Pack at the IBA Cosmetics Convergence Fall 2024 Virtual Symposium, “The Promise and Pitfalls of TikTok Shop.”
Global beauty giant is working to adapt its approach to the prestige market to meet escalating competition, increased points of sale, and more knowledgeable consumers with new shopping habits, CFO Tracey Travis said at the Barclays Global Consumer Staples Conference.
The gut’s microbiome will shape future medical advances, offering personalized therapies and prevention strategies for a wide range of diseases.
A look at new research on the cardiovascular effects of ADHD medications and what it means for clinical care. This article explores the latest clinical and epidemiological research on the cardiovascular effects of medications commonly prescribed for ADHD, examining potential heart-related risks, underlying mechanisms, and their implications for patient safety, clinical decision-making, and long-term treatment strategies across diverse age groups and risk profiles.
